Short Sellers Back Off Major Biotechs
The January 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The January 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The December 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The December 14 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
The top analyst upgrades, downgrades and other research calls from Friday included Apple, Applied Materials, Biogen, CyberArk, Electronic Arts, Marathon, Nike and NXP Semiconductors.
The top analyst upgrades, downgrades and initiations seen on Wednesday included Apple, Baker Hughes, Biogen, FedEx, Intel, Micron Technology, Roku and Shake Shack.
The November 30 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
The November 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Here 24/7 Wall St. takes a look at a recent report by Canaccord Genuity regarding to biotech and pharmaceutical companies expecting updates to their drug pipeline or other major events for the…
The October 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
The October 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Here is a preview of some of the world’s largest players in the health care sector reporting earnings this coming week.
The top analyst upgrades, downgrades and initiations seen on Friday included Alphabet, American Express, Apple, Biogen, eBay, Ford, Microsoft, PPG, Roku, United Rentals and Valero Energy.
The September 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Merrill Lynch recently highlighted sectors it considers a good opportunity now that are likely to outperform in the near term, and the sector that rated highest was biotechnology.
The September 14 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.